CyTuVax's Unattributed VC Round

CyTuVax raised a round of funding on October 25, 2012. Investors include Nedermaas Ventures.

CyTuVax has developed an intelligent vaccination platform technology for the treatment of cancer. The vaccination technology consists of a powerful adjuvant composed of depot-bound cytokines acting as…

Articles about CyTuVax's Unattributed VC Round: